Skip to main content
NCBI home page
Cytotechnology logoLink to Cytotechnology
. 1998 Sep;27(1-3):321–344. doi: 10.1023/A:1008066216490

Regulation of keratin and integrin gene expression in cancer and drug resistance

Noel Daly 1, Paula Meleady 1, Derek Walsh 1, Martin Clynes 1
PMCID: PMC3449561  PMID: 19002802

Full Text

The Full Text of this article is available as a PDF (176.8 KB).

References

  1. Abe M, Oshima RG. A single human keratin K18 gene is expressed in diverse epithelial cells of transgenic mice. J Cell Biol. 1990;111:1197–1206. doi: 10.1083/jcb.111.3.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams JC, Watt FM. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature. 1989;340:307–309. doi: 10.1038/340307a0. [DOI] [PubMed] [Google Scholar]
  3. Agura ED, Howard M, Collins SJ. Identification and sequence analysis of the promoter for the leukocyte integrin beta-subunit (CD18): A retinoic acid-inducible gene. Blood. 1992;79:602–609. [PubMed] [Google Scholar]
  4. Akiyama SK, Olden K, Yamada KM. Fibronectin and integrins in invasion and metastasis. Can Metas Rev. 1995;14:71–189. doi: 10.1007/BF00690290. [DOI] [PubMed] [Google Scholar]
  5. Albelda SM, Mette SA, Elder DA, Stewart R, Damjanovich L, Herlyn M, Buck CA. Integrin distribution in malignant melanoma: association of the γ3 subunit with tumor progression. Cancer Res. 1990;50:6757–6764. [PubMed] [Google Scholar]
  6. Albelda S. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Laboratory Investigation. 1993;68(1):4–17. [PubMed] [Google Scholar]
  7. Anastassiou G, Duensing S, Steinhoff G, Kirchner H, Ganser A, Atzpodien J. In vivodistribution of integrin in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumour differentiation and VLA-2 involvement in tumor metastasis. Cancer Biother. 1995;10(4):287–292. doi: 10.1089/cbr.1995.10.287. [DOI] [PubMed] [Google Scholar]
  8. Anderson JM, Heindl LM, Bauman PA, Ludi CW, Dalton WS, Cress AE. Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents. Clin Cancer Res. 1996;2:97–105. [PubMed] [Google Scholar]
  9. Aoshiba K, Rennard SI, Spurzem JR. Cell-matrix and cell-cell interactions modulate apoptosis of bronchial epithelial cells. Am J Physiol. 1997;272:L28–L37. doi: 10.1152/ajplung.1997.272.1.L28. [DOI] [PubMed] [Google Scholar]
  10. Arihiro K, Inai K, Kurihara K, Takada S, Kaneko M, Kuroi, Tog T. Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis. Jpn J Cancer Res. 1993;84:726–733. doi: 10.1111/j.1349-7006.1993.tb02036.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bauman PA, Dalton WS, Anderson JM, Cress AE. Expression of cytokeratin confers multiple drug resistance. Proc Natl Acad Sci USA. 1994;91:5311–5314. doi: 10.1073/pnas.91.12.5311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ben-Ze'ev A, Zöller M and Raz A (1986) Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumour. Cancer Res 46: 785-790. [PubMed]
  13. Bernstein ML, Leclerc JM, Bunin G, Brisson L, Robison L, Shuster J, Byrne T, Bregory D, Hill G, Dougherty G, Scriver C, Lemieux B, Tuchman M, Woods WG. A population-based study of the neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol. 1992;10:323–329. doi: 10.1200/JCO.1992.10.2.323. [DOI] [PubMed] [Google Scholar]
  14. Biedler JL, Casals D, Chang TD, Meyers MB, Spengler BA, Ross RA. Multi-drug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation. In: Evans AE, D'Angi GJ, editors. Advances in neuroblastoma research. New York: Wiley-Liss; 1991. pp. 181–191. [PubMed] [Google Scholar]
  15. Birkenmeier TM, McQuillan JJ, Boedeker ED, Argraves WS, Rouslahti E, Dean DC. The alpha 5 beta 1 fibronectin receptor. Characterisation of the alpha 5 gene promoter. J Biol Chem. 1991;266:20544–20549. [PubMed] [Google Scholar]
  16. Bisgaard HC, Ton PT, Nagy P, Thorgeirsson SS. Phenotypic modulation of keratins, vimentin and α-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation. J Cell Physiol. 1994;159:485–494. doi: 10.1002/jcp.1041590313. [DOI] [PubMed] [Google Scholar]
  17. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H. Mol Cell Biol. 1993;13:5216–5224. doi: 10.1128/mcb.13.9.5216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Blouin R, Swierenga SHM, Marceau N. Evidence for post-transcriptional regulation of cytokeratin gene expression in a rat liver epithelial cell line. Biochem Cell Biol. 1992;70:1–9. doi: 10.1139/o92-001. [DOI] [PubMed] [Google Scholar]
  19. Blumenberg M. Concerted gene duplications in the two keratin gene families. J Mol Evol. 1988;27:203–211. doi: 10.1007/BF02100075. [DOI] [PubMed] [Google Scholar]
  20. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267:891–893. doi: 10.1126/science.7531366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Briesewitz R, Epstein MR, Marcantonio EE. Expression of native and truncated forms of the human integrin α1 subunit. J Biol Chem. 1993;268(4):2989–2996. [PubMed] [Google Scholar]
  22. Brooks PC, Montgomery AMP, Rosenfeld M, Eisfeld RA, Hu T, Klier G, Cheresch DA. Integrin αvβ3antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157–1164. doi: 10.1016/0092-8674(94)90007-8. [DOI] [PubMed] [Google Scholar]
  23. Buck CA, Horwitz AF. Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol. 1987;3:179–205. doi: 10.1146/annurev.cb.03.110187.001143. [DOI] [PubMed] [Google Scholar]
  24. Casanova L, Bravo A, Were F, Ramirez A, Jorcano JJ, Vidal M. Tissue-specific and efficient expression of the human simple epithelial keratin 8 gene in transgenic mice. J Cell Biol. 1995;108:811–820. doi: 10.1242/jcs.108.2.811. [DOI] [PubMed] [Google Scholar]
  25. Ceratto N, Dobkin C, Carter M, Jenkins E, Yao XL, Cassiman JJ, Aly MS, Bosco P, Leube R, Langbein L, Feo S, Romano V. Human type I cytokeratin genes are a compact cluster. Cytogenet Cell Genet. 1997;77:169–174. doi: 10.1159/000134566. [DOI] [PubMed] [Google Scholar]
  26. Cervella P, Silengo L, Pastore C, Altruda F. Human β1-integrin gene expression is regulated by two promoter regions. J Biol Chem. 1993;268(7):5148–5155. [PubMed] [Google Scholar]
  27. Chan BMC, Matsuura N, Takada Y, Zetter BR, Hemler ME. In vitroand in vivoconsequences of VLA-2 expression of rhabdomyosarcoma cells. Science. 1991;251:1600–1602. doi: 10.1126/science.2011740. [DOI] [PubMed] [Google Scholar]
  28. Chen F-A, Alosco T, Croy BA, Narumi K, Percy DH, Bankert RB. Clones of tumour cells derived from a single primary human lung tumour reveal different patterns of β1 integrin expression. Cell Adhes Comm. 1994;2:345–357. doi: 10.3109/15419069409014209. [DOI] [PubMed] [Google Scholar]
  29. Chen H-C, Kinch MS, Lin TH, Nurridge K, Juliano RL. Integrin mediated cell adhesion activates mitogen activated protein kinases. J Biol Chem. 1994;269:26602–26605. [PubMed] [Google Scholar]
  30. Chintala SK, Sawaya R, Gokaslan ZL, Rao JS. Modulation of matrix metalloprotease-2 and invasion in human glioma cells by α3β1 integrin. Can Lett. 1996;103:201–208. doi: 10.1016/0304-3835(96)04215-2. [DOI] [PubMed] [Google Scholar]
  31. Chu Y-W, Runyan R, Oshima RG, Hendrix MJC. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc Natl Acad Sci USA. 1993;90:4261–4265. doi: 10.1073/pnas.90.9.4261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Chu Y-W, Seftor EA, Romer LH, Hendrix MJC. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol. 1996;148:63–69. [PMC free article] [PubMed] [Google Scholar]
  33. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science. 1995;268:233–239. doi: 10.1126/science.7716514. [DOI] [PubMed] [Google Scholar]
  34. Clarke AS, Lotz MM, Chao C, Mercurio AM. Activation of the p21 pathway of growth arrest and apoptosis by the beta (4) integrin cytoplasmic domain. J Biol Chem. 1995;270:22673–22676. doi: 10.1074/jbc.270.39.22673. [DOI] [PubMed] [Google Scholar]
  35. Clarke MR, Landreneau RJ, Finkelstein SJ, Wu TT, Ohori P, Yousem SA. Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. Hum Pathol. 1997;27(1):54–59. doi: 10.1016/s0046-8177(97)90279-3. [DOI] [PubMed] [Google Scholar]
  36. Corbi AL, Lopez-Rodriguez C. CD11c integrin gene promoter activity during myeloid differentiation. Leuk Lymph. 1997;25:415–425. doi: 10.3109/10428199709039028. [DOI] [PubMed] [Google Scholar]
  37. Conforti G, Codegoni AM, Scanziani E, Dolfini E, Dasdia T, Calza M, Caniatti M, Broggini M. Different vimentin expression in two clones derived from a human colon carcinoma cell line (LoVo) showing different sensitivity to doxorubicin. Br J Cancer. 1995;71:505–511. doi: 10.1038/bjc.1995.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Cremisi C, Duprey P. A labile inhibitor blocks endo A gene transcription in murine undifferentiated embryonal carcinoma cells. Nuc Acids Res. 1989;15:6105–6116. doi: 10.1093/nar/15.15.6105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Cress AE, Dalton WS. Multiple drug resistance and intermediate filaments. Can Metas Rev. 1996;15:499–506. doi: 10.1007/BF00054015. [DOI] [PubMed] [Google Scholar]
  40. Damjanovich L, Albelda SM, Mette SA, Buck CA. Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol. 1992;6:197–206. doi: 10.1165/ajrcmb/6.2.197. [DOI] [PubMed] [Google Scholar]
  41. Danen EHJ, Jansen KFJ, Van Kraats AA, Cornelissen IMHA, Ruiter DJ, Van Muijen GNP. αv integrins in human melanoma: Gain of αvβ3and loss of αvβ5are related to tumour progression in situbut not to metastatic capacity of cell lines in nude mice. Int J Can. 1995;61:491–496. doi: 10.1002/ijc.2910610411. [DOI] [PubMed] [Google Scholar]
  42. Danen EHJ, Van M., GNP a., Ruiter DJ. Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma. Cancer Surveys. 1995;24:43–65. [PubMed] [Google Scholar]
  43. Daniel JL, Dangelmaier C, Smith JB. Evidence for a role for tyrosine phosphorylation of phospholipase Cγ2 in collagen induced platelet cytosolic mobilisation. Biochem J. 1992;302:617–622. doi: 10.1042/bj3020617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. D'Ardenne AJ, Richman PI, Horton MA, Mcaulay AE and Jordan S (1991) Co-ordinate expression of alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer. J Pathol 165: 213-220. [DOI] [PubMed]
  45. Darmon M. Coexpression of specific acid and basic cytokeratins in teratocarcinoma-derived fibroblasts treated with 5-azacytidine. Dev Biol. 1985;110:47–52. doi: 10.1016/0012-1606(85)90062-4. [DOI] [PubMed] [Google Scholar]
  46. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;269:26602–26605. [PubMed] [Google Scholar]
  47. Day ML, Foster RG, Day KC, Zhao X, Humphrey P, Swanson P, Postigo AA, Zhang SH, Dean DC. Cell anchorage regulates apoptosis through the retinoblastoma tumour suppressor/E2F pathway. J Biol Chem. 1997;272(13):125–8128. doi: 10.1074/jbc.272.13.8125. [DOI] [PubMed] [Google Scholar]
  48. Dedhar S, Hannigan GE. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol. 1996;8:657–669. doi: 10.1016/s0955-0674(96)80107-4. [DOI] [PubMed] [Google Scholar]
  49. Defilippi P, Bozzo C, Volpe G, Romano G, Venturino M, Silengo L, Tarnone G. Integrin-mediated signal transduction in human endothelial cells: analysis of tyrosine phosphorylation events. Cell Adhes Commun. 1994;2:75–86. doi: 10.3109/15419069409014203. [DOI] [PubMed] [Google Scholar]
  50. Deuel TF, Kawahara RS, Mustoe TA, Pierce GF. Growth factors and wound healing-platelet-derived growth factor as a model cytokine. Annu Rev Med. 1991;42:567–584. doi: 10.1146/annurev.me.42.020191.003031. [DOI] [PubMed] [Google Scholar]
  51. Dodemont H, Reimer D, Weber K. Structure of an invertebrate gene encoding cytoplasmic intermediate filament (IF) proteins: implications for the origin and the diversification of IF proteins. EMBO. 1990;9:4083–4094. doi: 10.1002/j.1460-2075.1990.tb07630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Döring V, Stick R. Gene Structure of nuclear lamin LIII of Xenopus laevis: a model for the evolution of IF proteins from a lamin-like ancestor. EMBO. 1990;9:4073–4081. doi: 10.1002/j.1460-2075.1990.tb07629.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Duensing S, Nunez FB, Meyer N, Anastassiou G, Nasarek A, Grosse J, Buer J, Probst M, Ganser A, Atzpodien J. Exposure to vinblastine modulates β1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line. Invasion Metas. 1996;16:65–72. [PubMed] [Google Scholar]
  54. Elices MJ, Osborn L, Takada Y, Crouse C, Lubkowski S, Hemler ME, Lobb RR. VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA/fibronectin binding site. Cell. 1990;60:577–584. doi: 10.1016/0092-8674(90)90661-w. [DOI] [PubMed] [Google Scholar]
  55. Fässler R, George-Labouesse E, Hirsch E. Genetic analysis of integrin function in mice. Curr Opin Cell Biol. 1996;8:641–646. doi: 10.1016/s0955-0674(96)80105-0. [DOI] [PubMed] [Google Scholar]
  56. Feldman LE, Shin KC, Natale RB, Todd R. Beta 1 integrin expression on human small cell lung cancer cells. Cancer Res. 1991;51:1065–1070. [PubMed] [Google Scholar]
  57. Ferrell JE, Martin GS. Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets. Proc Natl Acad Sci USA. 1989;86:2234–2238. doi: 10.1073/pnas.86.7.2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Francy AJM, Van d., Klundert J, Raats MH, Bloemendahl H. Intermediate filaments: regulation of gene expression and assembly. Eur J Biochem. 1993;214:351–366. doi: 10.1111/j.1432-1033.1993.tb17931.x. [DOI] [PubMed] [Google Scholar]
  59. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619–626. doi: 10.1083/jcb.124.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Fuchs E. Keratins as biochemical markers of epithelial differentiation. Trends Genet. 1988;4:277–281. doi: 10.1016/0168-9525(88)90169-2. [DOI] [PubMed] [Google Scholar]
  61. Fujii K. Ligand activation of overexpressed epidermal growth factor receptor results in loss of epithelial phenotype and impaired RGD-sensitive integrin function in HSC-1 cells. J Invest Dermatol. 1996;107(2):195–202. doi: 10.1111/1523-1747.ep12329606. [DOI] [PubMed] [Google Scholar]
  62. Fujimura Y, Yamamoto H, Hamazato F, Nozaki M. One of the two Ets-binding sites in the cytokeratin EndoA enhancer is essential for enhancer activity and binds to Ets-2 related proteins. Nuc Acids Res. 1994;22:613–618. doi: 10.1093/nar/22.4.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol. 1994;6:717–725. doi: 10.1016/0955-0674(94)90099-x. [DOI] [PubMed] [Google Scholar]
  64. Giancotti F, Ruoslahti E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of chinese hamster ovary cells. Cell. 1990;60:849–859. doi: 10.1016/0092-8674(90)90098-y. [DOI] [PubMed] [Google Scholar]
  65. Gong J, Wang D, Sun L, Zborowska E, Willson JKV, Brattain M. Role of α5β1 integrin in determining the malignant properties of colon carcinoma cells. Cell Growth Diff. 1997;8:83–90. [PubMed] [Google Scholar]
  66. Guadango TM, Ohstubo M, Roberts JM, Assoian RK. A link between cyclin A expression and adhesion-dependent cell cycle proliferation. Science. 1993;262:1572–1575. doi: 10.1126/science.8248807. [DOI] [PubMed] [Google Scholar]
  67. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996;84:345–357. doi: 10.1016/s0092-8674(00)81279-9. [DOI] [PubMed] [Google Scholar]
  68. Hafez MM, Hsu S, Yan Z, Winawer S, Friedman E. Two roles for transforming growth factor β1 in colon enterocytic cell differentiation. Cell Growth Diff. 1992;3:753–762. [PubMed] [Google Scholar]
  69. Heino J. Biology of tumour cell invasion: interplay of cell adhesion and matrix degradation. Int J Cancer. 1996;65:717–722. doi: 10.1002/(SICI)1097-0215(19960315)65:6<717::AID-IJC1>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  70. Heino J, Massague J. Transforming growth factor-beta switches the pattern of integrins expressed in Mg-63 human oesteosarcoma cells and causes a selective loss of cell adhesion to lamina. J Biol Chem. 1989;264:21806–21811. [PubMed] [Google Scholar]
  71. Heino J, Ignotz RA, Hemler ME, Crouse C, Massagué J. Regulation of cell adhesion receptors by transforming growth factor-β. J Biol Chem. 1989;264(1):380–388. [PubMed] [Google Scholar]
  72. Hemler ME, Huang C, Schwarz L. The VLA Protein Family. J Biol Chem. 1987;262(7):3300–3309. [PubMed] [Google Scholar]
  73. Hendrix MJ, Seftor EA, Chu Y, Seftor REB, Nagle RB, Mc-Daniel KM, Leong SPL, Yohem KH, Leibovitz AM, Meyskens FL, Conaway DH, Welch DR, Liotta LA, Stetler-Stevens M. Coexpression of vimentin and keratins by human melanoma tumor cells: a correlation with invasive and metaplastic potential. J Natl Cancer Inst. 1992;84:165–174. doi: 10.1093/jnci/84.3.165. [DOI] [PubMed] [Google Scholar]
  74. Hendrix MJC, Seftor EA, Chu Y-W, Trevor KT, Seftor REB. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metas Rev. 1996;15:507–525. doi: 10.1007/BF00054016. [DOI] [PubMed] [Google Scholar]
  75. Hendrix MJC, Seftor EA, Seftor REB, Trevor KT. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Amer J Pathol. 1997;150:483–495. [PMC free article] [PubMed] [Google Scholar]
  76. Hibbs ML, Xu H., Stacker SA, Springer TA. Regulation of adhesion of ICAM-1 by the cytoplasmic domain of LFA-1 integrin β subunit. Science. 1991;251:1611–1613. doi: 10.1126/science.1672776. [DOI] [PubMed] [Google Scholar]
  77. Hickstein DD, Baker DM, Gollahon KA, Back AL. Identification of the promoter of the myelomonocytic leukocyte integrin CD11b. Proc Natl Acad Sci USA. 1992;89:2105–2109. doi: 10.1073/pnas.89.6.2105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Hillis GS, MacLeod AM. Integrins and disease. Clin Sci. 1996;91:639–650. doi: 10.1042/cs0910639. [DOI] [PubMed] [Google Scholar]
  79. Horwitz A (1997) Integrins and Health. Scientific American May: 46-53. [DOI] [PubMed]
  80. Howlett AR, Bailey N, Damsky C, Peterson OW, Bissell M. Cellular growth and survival are mediated by β1 integrins in normal human breast epithelium but not in breast carcinoma. J Cell Sci. 1995;108:1945–1957. doi: 10.1242/jcs.108.5.1945. [DOI] [PubMed] [Google Scholar]
  81. Humphries MJ. The molecular basis and specificity of integrin-ligand interactions. J Cell Sci. 1990;97:585–592. doi: 10.1242/jcs.97.4.585. [DOI] [PubMed] [Google Scholar]
  82. Hynes RO. Integrins: A family of cell surface receptors. Cell. 1987;48:549–554. doi: 10.1016/0092-8674(87)90233-9. [DOI] [PubMed] [Google Scholar]
  83. Ichinose Y, Morita T, Zhang F, Srimahasongcram S, Tondella MLC, Matsumoto M, Nozaki M, Matsushiro A. Nucleotide sequence and structure of the mouse cytokeratin endoB gene. Gene. 1988;70:85–95. doi: 10.1016/0378-1119(88)90107-2. [DOI] [PubMed] [Google Scholar]
  84. Ignatius MJ, Large TH, Houde M, Tawil JW, Barton A, Esch F, Carbonetta S, Reichardt LF. Molecular cloning of the rat integrin α1-subunit: A receptor for laminin and collagen. J Cell Biol. 1990;111:709–720. doi: 10.1083/jcb.111.2.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Ignotz RA, Heino J, Massague J. Regulation of cell adhesion receptors by transforming growth factor-β. J Biol Chem. 1989;264(1):389–392. [PubMed] [Google Scholar]
  86. Jackson BW, Grund C, Schmid E, Burki K, Franke WW, Illmensee K. Formation of cytoskeletal elements during mouse embryogenesis. Intermediate filaments of the cytokeratin type and desmosomes in preimplantation embryos. Differentiation. 1980;17:161–179. doi: 10.1111/j.1432-0436.1980.tb01093.x. [DOI] [PubMed] [Google Scholar]
  87. Jensen PJ, Wheelock MJ. The relationships among adhesion, stratification and differentiation in keratinocytes. Cell Death Diff. 1996;3:357–371. [PubMed] [Google Scholar]
  88. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell. 1993;73:713–724. doi: 10.1016/0092-8674(93)90251-k. [DOI] [PubMed] [Google Scholar]
  89. Jones PH, Harper S, Watt FM. Stem cell patterning and fate in human epidermis. Cell. 1995;80:83–93. doi: 10.1016/0092-8674(95)90453-0. [DOI] [PubMed] [Google Scholar]
  90. Judware R, Culp LA. Concomitant down-regulation of integrin subunits by N-mycin human neurobastoma cells: differential regulation of α2, α3 and β1. Oncogene. 1997;14:1341–1350. doi: 10.1038/sj.onc.1200955. [DOI] [PubMed] [Google Scholar]
  91. Judware R, Culp LA. N-mycover-expression downregulates α3β1 integrin expression in human Saos-2 osteosarcoma cells. Clin Exp Metastasis. 1997;15:228–238. doi: 10.1023/a:1018417330479. [DOI] [PubMed] [Google Scholar]
  92. Kanner SB, Grosmaire LS, Ledbetter JA, Damle NK. β2-integrin LFA-1 signalling through phospholipase C-γ1 activation. Proc Natl Acad Sci USA. 1993;90:7099–7103. doi: 10.1073/pnas.90.15.7099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Kapron-Bras C, Fitz-Gibbon L, Jeevaratnam P, Wilkins J, Dedhar S. Integrin clustering stimulates p21 ras activation. J Biol Chem. 1993;268:20701–20704. [PubMed] [Google Scholar]
  94. Kassner PD, Kawaguchi S, Hemler ME. Minimum α chain cytoplastic tail sequence needed to support integrin-mediated adhesion. J Biol Chem. 1994;269:19859–19867. [PubMed] [Google Scholar]
  95. Katabami M, Fujita H, Honke K, Makita A, Akita H, Miyamoto H, Kawakami Y, kuzumaki N. Marked reduction of type I keratin (K14) in cisplatin-resistant human lung squamous-carcinoma cell lines. Biochem Pharm. 1993;45:1703–1710. doi: 10.1016/0006-2952(93)90312-k. [DOI] [PubMed] [Google Scholar]
  96. Keely PJ, Fong AM, Zutter MM, Santoro SA. Alternation of collagen-dependant adhesion motility and morphogensis by the expression of antisense α2 integrin mRNA in mammary cells. J Cell Sci. 1995;108:595–607. doi: 10.1242/jcs.108.2.595. [DOI] [PubMed] [Google Scholar]
  97. Khawja A, Rodriguez-Viciana P, Wennström S, Warne PH, Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein B/Akt cellular survival pathway. EMBO J. 1997;16(10):2783–2793. doi: 10.1093/emboj/16.10.2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Kim LT, Yamada KY. The regulation of expression of integrin receptors. Proc Soc Exp Biol Med. 1997;214(2):123–131. doi: 10.3181/00379727-214-44078. [DOI] [PubMed] [Google Scholar]
  99. Kirchhofer D, Languino LR, Ruoslahti E, Pierschbacher MD. α2β1 integrins from different cell types show different binding specificities. J Biol Chem. 1990;265:615–618. [PubMed] [Google Scholar]
  100. Klein CE, Dresel D, Steinmayer T, Mauch C, Eckes B, Krieg T, Bankert RB, Weber L. Integrin α2β1 is upregulated in fibroblasts and highly agressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol. 1991;115:1427–1436. doi: 10.1083/jcb.115.5.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Klemz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell. 1990;61:113–124. doi: 10.1016/0092-8674(90)90219-5. [DOI] [PubMed] [Google Scholar]
  102. Knapp AC, Franke WW. Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell. 1989;59:67–79. doi: 10.1016/0092-8674(89)90870-2. [DOI] [PubMed] [Google Scholar]
  103. Knox JD, Cress AE, Clark V, Manriquez L, Affinito KS, Dalkin BL, Nagle RB. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol. 1994;145:167–174. [PMC free article] [PubMed] [Google Scholar]
  104. Koretz K, Schlag P, Boumsell L, Möller P. Expression of VLA-α2, VLA-α6, and VLA-β1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am J Pathol. 1991;138(3):741–750. [PMC free article] [PubMed] [Google Scholar]
  105. Korhonen M, Laitinen L, Ylänne J, Koukoulis GK, Quaranta V, Juusela H, Gould VE, Virtanen I. Integrin distributions in renal cell carcinomas of various grades of malignancy. Am J Pathol. 1992;141(5):1161–1171. [PMC free article] [PubMed] [Google Scholar]
  106. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL. Signal transduction by integrins: increased tyrosine phosphorylation caused by clustering of β1 integrins. Proc Natl Acad Sci USA. 1991;88:8392–8396. doi: 10.1073/pnas.88.19.8392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Kosmehl H, Berndt A, Katenkamp D, Hyckel P, Stiller KJ, Gabler U, Langbein L, Reh T. Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study. J Oral Pathol Med. 1995;24:343–348. doi: 10.1111/j.1600-0714.1995.tb01197.x. [DOI] [PubMed] [Google Scholar]
  108. Koukoulis GK, Virtanen I, Korhonen M, Laitinen L, Quaranta V, Gould VE. Immunohistochemical localisation of integrins in the normal, hyperplastic, and neoplastic breast. Am J Pathol. 1991;139:787–799. [PMC free article] [PubMed] [Google Scholar]
  109. Koukoulis GK, Virtanen I, Moll R, Quaranta V, Gould VE. Immunolocalisation of integrins in the normal and neoplastic colon epithelium. Virchows Archivs. 1993;63:373–383. doi: 10.1007/BF02899286. [DOI] [PubMed] [Google Scholar]
  110. Krauss S, Franke WW. Organization and sequence of the human gene encoding cytokeratin 8. Gene. 1990;86:241–249. doi: 10.1016/0378-1119(90)90285-y. [DOI] [PubMed] [Google Scholar]
  111. Kulesh DA, Oshima RG. Cloning of the human keratin 18 gene and its expression in nonepithelial mouse cells. Mol Cell Biol. 1988;8:1540–1550. doi: 10.1128/mcb.8.4.1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Kulesh DA, Cecena G, Darmon YM, Vasseur M, Oshima RG. Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol Cell Biol. 1989;9:1553–1565. doi: 10.1128/mcb.9.4.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Kulesh DA, Oshima RG. Complete structure of the gene for human keratin 18 gene. Genomics. 1989;4:339–347. doi: 10.1016/0888-7543(89)90340-6. [DOI] [PubMed] [Google Scholar]
  114. Kumar NM, Sigurdson SL, Sheppard D, Lwebuga-Mukasa JS. Differential modulation of integrin receptors and extra-cellular matrix laminin by transforming growth factor-β1 in rat alveolar epithelial cells. Exp Cell Res. 1995;221:385–394. doi: 10.1006/excr.1995.1389. [DOI] [PubMed] [Google Scholar]
  115. LaFlamme SE, Auer KL. Integrin signalling. Stem Cell Biol. 1996;7:111–118. doi: 10.1006/scbi.1996.0016. [DOI] [PubMed] [Google Scholar]
  116. LaFlamme SE, Akiyama SK, Yamada KM. Regulation of fibronectin receptor distribution. J Cell Biol. 1992;124:1047–1059. doi: 10.1083/jcb.117.2.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Leask A, Rosenberg M, Vassar R, Fuchs E. Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes Dev. 1990;4:1985–1988. doi: 10.1101/gad.4.11.1985. [DOI] [PubMed] [Google Scholar]
  118. Ledinko N, Costantino RL. Modulation of p53 gene expression and cytokeratin 18 in retinoid-mediated invasion suppressed lung carcinoma cells. Anticancer Res. 1990;10:1335–1339. [PubMed] [Google Scholar]
  119. Liao J, Lowthert LA, Ghori N, Omary MB. The 70-kDa heat shock proteins associate with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem. 1995;270:915–922. doi: 10.1074/jbc.270.2.915. [DOI] [PubMed] [Google Scholar]
  120. Liao J, Omary MB. 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J Cell Biol. 1995;133:345–357. doi: 10.1083/jcb.133.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Lin C-S, Chen Y, Huynh T, Kramer R. Identification of the human α6 gene promoter. DNA Cell Biol. 1997;16(8):929–937. doi: 10.1089/dna.1997.16.929. [DOI] [PubMed] [Google Scholar]
  122. Lin C-S, Zhang K, Kramer R. α6 integrin is up-regulated in step-increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts. Cancer Res. 1993;53:2950–2953. [PubMed] [Google Scholar]
  123. Lin TH, Yurochko A, Komberg L, Morris J, Walker JJ, Haskill S, Juliano R. The role of protein tyrosine phosphorylation in integrin-mediated gene induction in monocytes. J Cell Biol. 1994;126:1585–1593. doi: 10.1083/jcb.126.6.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Liotta LA. Tumour invasion and metastasis: role of extracellular matrix. Cancer Res. 1986;46:1–7. doi: 10.1016/S0065-230X(08)60034-2. [DOI] [PubMed] [Google Scholar]
  125. Loeser RF. Growth factor regulation of chondrocyte integrins. Arthritus Rheum. 1997;40(2):270–276. doi: 10.1002/art.1780400211. [DOI] [PubMed] [Google Scholar]
  126. Lopez-Rodriguez C, Corbi AL. PU.1 negatively regulates the CD11c integrin gene promoter through recognition of the major transcriptional start site. Eur J Immunol. 1997;27:1843–1847. doi: 10.1002/eji.1830270804. [DOI] [PubMed] [Google Scholar]
  127. Lopez-Rodriguez C, Zubiaur M, Sancho J, Concha A, Corbi AL. An octamer element functions as a regulatory element in the differentiation-responsive CD11c integrin gene reporter. J Immunol. 1997;158:5833–5840. [PubMed] [Google Scholar]
  128. McGill G, Shimamura A, Bates RC, Savage RE, Fisher DE. Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol. 1997;138(4):901–911. doi: 10.1083/jcb.138.4.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Meredith J, Takada Y, Fornaro M, Languino LR, Schwartz MA. Inhibition of cell cycle progression by the alternatively spliced integrin β1C. Science. 1995;269:1570–1572. doi: 10.1126/science.7545312. [DOI] [PubMed] [Google Scholar]
  130. Miao J-Y, Araki S, Kaji K, Hayashi H. Integrin β4 is involved in apoptotic signal transduction in endothelial cells. Biochem Biophys Res Comm. 1997;233:182–186. doi: 10.1006/bbrc.1997.6422. [DOI] [PubMed] [Google Scholar]
  131. Miyashita T, Yamamoto H, Takemoto Y, Nozaki M, Morita T, Matushiro A. Identification of differentiation-dependent DNase-I hypersensitive sites in the mouse EndoA gene. Gene. 1993;125:151–158. doi: 10.1016/0378-1119(93)90322-t. [DOI] [PubMed] [Google Scholar]
  132. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11–24. doi: 10.1016/0092-8674(82)90400-7. [DOI] [PubMed] [Google Scholar]
  133. Moran E, Cleary I, Larkin AM, Nic Amhlaoibh R, Masterson A, Scheper RJ, Izquierdo MA, Center M, O'Sullivan F. Co-expression of MDR-associated markers, including p-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42. Eur J Cancer. 1997;33:652–660. doi: 10.1016/s0959-8049(96)00501-1. [DOI] [PubMed] [Google Scholar]
  134. Morino N, Minura T, Hamasaki K, Tobe K, Ueki K, Kikuchi K, Takehara K, Kadowaki T, Yazaki Y, Nojima Y. Matrix/integrin interaction activates the mitogen-activated protein kinases, p44erk-1 and p42erk-2. J Biol Chem. 1995;270:269–273. doi: 10.1074/jbc.270.1.269. [DOI] [PubMed] [Google Scholar]
  135. Morita T, Tondella MLC, Takemoto Y, Hashido K, Ichinose Y, Nozaki M, Matsushiro A. Nucleotide sequence of mouse EndoA cytokeratin cDNA reveals polypeptide characteristics of the type-II keratin subfamily. Gene. 1988;68:109–117. doi: 10.1016/0378-1119(88)90604-x. [DOI] [PubMed] [Google Scholar]
  136. Mortarini R, Anichini A, Parmiani G. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins. Int J Cancer. 1991;47:551–559. doi: 10.1002/ijc.2910470413. [DOI] [PubMed] [Google Scholar]
  137. Mukhopadhyay T, Roth JA. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines. Anticanc Res. 1996;16:105–112. [PubMed] [Google Scholar]
  138. Mukhopadhyay T, Roth JA. Functional inactivation of p53 by antisense RNA induces invasive ability of lung carcinoma cells and downregulates cytokeratin synthesis. Anticanc Res. 1996;16:1683–1690. [PubMed] [Google Scholar]
  139. Narita T, Kawakami-Kimura N, Sato M, Matsuura N, Higashiyama S, Taniguchi N, Kannagi R. Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells. Oncology. 1996;53:374–381. doi: 10.1159/000227591. [DOI] [PubMed] [Google Scholar]
  140. Natali PG, Hamby CV, Felding-Habermann B, Liamg L, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S. Clinical significance of αvβ3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res. 1997;57:1554–1560. [PubMed] [Google Scholar]
  141. Newham P and Humphries MJ (1996) Integrin adhesion receptors: structure, function and implications for biomedicine. Molecular Medecine Today July: 304-313. [DOI] [PubMed]
  142. Neznanov NS, Oshima RG. cis regulation of the keratin 18 gene in transgenic mice. Mol Cell Biol. 1993;13:1815–1823. doi: 10.1128/mcb.13.3.1815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Neznanov NS, Umezawa A, Oshima RG. A regulatory element within a coding exon modulates keratin 18 gene expression in transgenic mice. J Biol Chem. 1997;272:27549–27557. doi: 10.1074/jbc.272.44.27549. [DOI] [PubMed] [Google Scholar]
  144. Nigam AK, Savage FJ, Boulos PB, Stamp GWH, Liu D, Pignatelli M. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer. 1993;68:507–514. doi: 10.1038/bjc.1993.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Nista A, Leonetti C, Bernardini G, Mattioni Mand Santoni A. Functional role of β4β1 and α5β1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int J Cancer. 1997;72:133–141. doi: 10.1002/(sici)1097-0215(19970703)72:1<133::aid-ijc19>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  146. Nista A, Mattioni M, Gismondi A, Palmieri G, Santoni A. β1-integrin expression and function in human bladder cancer cells: modulation by TNFα. Anticancer Res. 1996;16:581–588. [PubMed] [Google Scholar]
  147. Omary MB, Baxter GT, Chou C-F, Riopel CL, Lin WY, Strulovici B. PKC∈-related kinase associates with and phosphorylates cytokeratin 8 and 18. J Cell Biol. 1992;117:583–593. doi: 10.1083/jcb.117.3.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Onclerq R, Lavenu A, Cremisi C. Pleitropic derepression of developmentally regulated cellular and viral genes by c-myc protooncogene products in undifferentiated embryonal carcinoma cells. Nuc Acids Res. 1989;17:735–753. doi: 10.1093/nar/17.2.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Oshima RG, Millan JL, Cecena G. Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation. Differentiation. 1986;33:61–68. doi: 10.1111/j.1432-0436.1986.tb00411.x. [DOI] [PubMed] [Google Scholar]
  150. Oshima RG, Trevor K, Shevinsky LH, Ryder OA, Cecena Identification of the gene coding for the Endo B murine cytokeratin and its methylated, stable inactive state in mouse nonepithelial cells. Genes Dev. 1988;2:505–516. doi: 10.1101/gad.2.5.505. [DOI] [PubMed] [Google Scholar]
  151. Oshima RG, Abrams L, Kulesh D. Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. Genes Dev. 1990;4:835–848. doi: 10.1101/gad.4.5.835. [DOI] [PubMed] [Google Scholar]
  152. Oshima RG, Baribault H, Caulin C. Oncogenic regulation and function of keratins 8 and K18. Cancer Metas Rev. 1996;15:445–471. doi: 10.1007/BF00054012. [DOI] [PubMed] [Google Scholar]
  153. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Kamura R, Quaranta V, Loftus JC, Shattil SJ and Ginsberg MH (1994) Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 124: 1047-1059. [DOI] [PMC free article] [PubMed]
  154. Pahl HL, Scheibe RJ, Zhang DE, Chen HM, Galson DL, Maki RA, Tenen DG. The proto-oncogene PU.1 regulates the expression of the myeloid-specific CD11b promoter. J Biol Chem. 1993;268:5014–5020. [PubMed] [Google Scholar]
  155. Paine ML, Gibbins JR, Chew KE, Demetriou A, Kefford RF. Loss of keratin expression in anaplastic carcinoma cells due to posttranscriptional down-regulation acting in-trans. Cancer Res. 1992;52:6603–6611. [PubMed] [Google Scholar]
  156. Pankov R, Neznanov N, Umezawa A, Oshima RG. AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol Cell Biol. 1994;14:7744–7757. doi: 10.1128/mcb.14.12.7744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Pankov R, Umezawa A, Maki R, Der CJ, Hauser CA, Oshima RG. Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc Natl Acad Sci USA. 1994;91:873–877. doi: 10.1073/pnas.91.3.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Pankov R, Simcha I, Zoller M, Oshima RG, Ben-Ze'ev A. Contrasting effects of K8 and K18 on stabilizing K19 expression, cell motility and tumorgenicity in the BSp73 adenocarcinoma. J Cell Science. 1997;110:965–974. doi: 10.1242/jcs.110.8.965. [DOI] [PubMed] [Google Scholar]
  159. Parekh HK, Simpkins H. The differential expression of cytokeratin 18 in cisplatin-sensitive and-resistant human ovarian adenocarcinoma cells and its association with drug sensitivity. Cancer Res. 1995;55:5203–5206. [PubMed] [Google Scholar]
  160. Parekh H, Simpkins H. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and-resistant rat lymphoma and human ovarian carcinoma cells. Cancer Chemother Pharmacol. 1996;37:457–462. doi: 10.1007/s002800050412. [DOI] [PubMed] [Google Scholar]
  161. Parsons JT. Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol. 1996;8:146–152. doi: 10.1016/s0955-0674(96)80059-7. [DOI] [PubMed] [Google Scholar]
  162. Pasqualini R, Hemler ME. Contrasting roles for integrin β1 and β5 cytoplasmic domains in subcellular localisation, cell proliferation, and cell migration. J Cell Biol. 1994;125:447–460. doi: 10.1083/jcb.125.2.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Pellegrini R, Martignone S, Ménard S, Ines Colnagh M. Laminin receptor expression and function in small-cell lung carcinoma. Int J Cancer. 1994;Supplement8:116–120. doi: 10.1002/ijc.2910570725. [DOI] [PubMed] [Google Scholar]
  164. Perrottin D, Cimino L, Falcioni R, Tibursi G, Gentileschi MP, Sacchi A. Metastatic phenotype growth factor dependence and integrin expression. Anticancer Res. 1990;10:1587–1597. [PubMed] [Google Scholar]
  165. Pignatelli M, Stamp S. Integrins in tumour development and spread. Cancer Surveys. 1995;24:113–127. [PubMed] [Google Scholar]
  166. Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol. 1994;25:849–856. doi: 10.1016/0046-8177(94)90002-7. [DOI] [PubMed] [Google Scholar]
  167. Pignatelli M, Cardillo MR, Hanby A, Stamp GWH. Integrins and their accessory adhesion molecules in mammary carcinomas. Hum Pathol. 1992;23:1159–1166. doi: 10.1016/0046-8177(92)90034-z. [DOI] [PubMed] [Google Scholar]
  168. Pignatelli M, Hanby A, Stamp G. Low expression of β1, α2 and α3 subunits of VLA integrins in malignant mammary tumours. J Pathol. 1991;165:25–32. doi: 10.1002/path.1711650106. [DOI] [PubMed] [Google Scholar]
  169. Pignatelli M, Smith MEF, Bodmer WF. Low expression of collagen receptors on moderate and poorly differentiated colorectal adenocarcinomas. Br J Can. 1990;61:636–638. doi: 10.1038/bjc.1990.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Ramaekers FCS, Haag D, Kant A, Moesker O, Jap PHK, Vooijs GP. Coexpression of keratin-and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA. 1983;80:2618–2622. doi: 10.1073/pnas.80.9.2618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Re F, Zanetti A, Siron M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F. Inhibition of anchorage-dependant cell spreading triggers apoptosis in cultured endothelial cells. J Cell Biol. 1994;127:537–546. doi: 10.1083/jcb.127.2.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70:389–399. doi: 10.1016/0092-8674(92)90163-7. [DOI] [PubMed] [Google Scholar]
  173. Riikoken T, Westermarck J, Koivistro L, Broberg A, Kähäri VM, Heino J. α2β1 integrin is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J Biol Chem. 1995;270:13548–13522. doi: 10.1074/jbc.270.22.13548. [DOI] [PubMed] [Google Scholar]
  174. Rivoltini L, Cattoretti G, Arienti F, Mastroianna A, Melani C, Colombo MP, Parmiani G. The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCAM and a less-differentiated phenotype. Int J Cancer. 1991;47:746–754. doi: 10.1002/ijc.2910470521. [DOI] [PubMed] [Google Scholar]
  175. Rosen GD, Birkenmeir TM, Dean DC. Characterization of the alpha 4 integrin gene promoter. Proc Natl Acad Sci USA. 1991;88:4094–4098. doi: 10.1073/pnas.88.10.4094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Ross SA, Ahrens RA, De Lucia L. Retinoic acid enhances adhesiveness, laminin and integrin β1 synthesis, and retinoic acid receptor expression in F9 teratocarcinoma cells. J Cell Physiol. 1994;159:263–273. doi: 10.1002/jcp.1041590210. [DOI] [PubMed] [Google Scholar]
  177. Roussel E, Gingras M-C, Ro JY, Branch C, Roth JA. Loss of α1β1 and reduced expression of other α1integrin and CAM in lung adenocarcinoma compared with pneumocytes. J Sur Onc. 1994;56:198–208. doi: 10.1002/jso.2930560315. [DOI] [PubMed] [Google Scholar]
  178. Rozzo C, Chiesa V, Carida G, Pagnan G, Ponzoni M. Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion. Int J Cancer. 1997;70:688–698. doi: 10.1002/(sici)1097-0215(19970317)70:6<688::aid-ijc11>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  179. Rubartelli A, Poggi A, Zocchi MR. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium. Eur J Immunol. 1997;27:1893–1900. doi: 10.1002/eji.1830270812. [DOI] [PubMed] [Google Scholar]
  180. Rubio MA, Sotillos M, Jochems G, Alvarez V, Corbí AL. Monocyte activation: rapid induction of α1/β1 (VLA-1) integrin expression by lipopolysaccharide and interferon-γ. Eur J Immunol. 1995;25:2701–2705. doi: 10.1002/eji.1830250945. [DOI] [PubMed] [Google Scholar]
  181. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion. Science. 1987;283:491–497. doi: 10.1126/science.2821619. [DOI] [PubMed] [Google Scholar]
  182. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell. 1994;77:537–546. doi: 10.1016/0092-8674(94)90209-7. [DOI] [PubMed] [Google Scholar]
  183. Ruoslahti E. Integrin signalling and matrix assembly. Tumor Biol. 1996;17:117–124. doi: 10.1159/000217975. [DOI] [PubMed] [Google Scholar]
  184. Ruoslahti E. Integrins as signalling molecules and targets for tumor therapy. Kidney Int. 1997;51:1413–1417. doi: 10.1038/ki.1997.193. [DOI] [PubMed] [Google Scholar]
  185. Sato M, Narita T, Kawakami-Kimura N, Higashiyama S, Taniguchi N, Akiyama S, Hashimoto T, Manabe T, Kannagi R. Increased expression of integrins by heparin-binding EGF like growth factor in human esophageal cancer cells. Cancer Letters. 1996;102:183–191. doi: 10.1016/0304-3835(96)04158-4. [DOI] [PubMed] [Google Scholar]
  186. Schlaepfer DD, Hanks SK, Hunter T, Van der Geer P. Integrin mediated signal transduction linked to Ras pathway by Grb2 binding to focal adhesion kinase. Nature. 1994;372:786–790. doi: 10.1038/372786a0. [DOI] [PubMed] [Google Scholar]
  187. Schmidhauser C, Casperson GF, Myers CA, Sanzo KT, Bolten S, Bissell MJ. A novel transcriptional enhancer is involved in the prolactin-and extracellular matrix-dependent regulation of beta-casein gene expression. Mol Biol Cell. 1992;3:699–709. doi: 10.1091/mbc.3.6.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Schreiner C, Fischer M, Hussein S, Juliano RL. Increased tumorigenicity of fibronectin receptor deficient chinese hamster ovary cell variants. Cancer Res. 1991;51:1738–1740. [PubMed] [Google Scholar]
  189. Schwartz MA, Lechene C, Ingber DE. Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin α5β1, independent of cell shape. Proc Natl Acad Sci USA. 1991;88:7849–7853. doi: 10.1073/pnas.88.17.7849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Scott G, Cassidy L, Busacco A. Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism. J Invest Dermatol. 1997;108:147–153. doi: 10.1111/1523-1747.ep12332650. [DOI] [PubMed] [Google Scholar]
  191. Seftor REB, Seftor EA, Gehilsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E, Hendrix MJC. Role of αvβ1 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA. 1993;89:1557–1561. doi: 10.1073/pnas.89.5.1557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Serra R, Carbonetto S, Lord M, Isom HC. Transforming growth factor β1 suppresses transformation in hepatocytes by regulating α1β1 integrin expression. Cell Growth Diff. 1994;5:509–517. [PubMed] [Google Scholar]
  193. Seth A, Robinson L, Panayiotakis A, Thompson DM, Hodge DR, Zhang XR, Watson DK, Ozato K, Papas TS. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins. Oncogene. 1994;9:469–477. [PubMed] [Google Scholar]
  194. Shelley CS, Arnaout MA. The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression. Proc Natl Acad Sci USA. 1991;88:10525–10529. doi: 10.1073/pnas.88.23.10525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Shen MR, Batzer MA, Deininger PL. Evolution of the master Alu gene(s) J Mol Evol. 1991;33:311–320. doi: 10.1007/BF02102862. [DOI] [PubMed] [Google Scholar]
  196. Singer PA, Trevor K, Oshima RG. Molecular cloning of the endoB cytokeratin expressed in preimplantation mouse embryos. J Biol Chem. 1986;261:538–547. [PubMed] [Google Scholar]
  197. Skalli O, Goldman RD. Recent insights into the assembly, dynamics, and function of intermediate filament networks. Cell Motility Cytoskel. 1991;19:67–79. doi: 10.1002/cm.970190202. [DOI] [PubMed] [Google Scholar]
  198. Smythe WR, LeBel E, Bavaria JE, Kaiser LR, Albelda SM. Integrin expression in non-small cell carcinoma of the lung. Can Metas Rev. 1995;14:229–239. doi: 10.1007/BF00690294. [DOI] [PubMed] [Google Scholar]
  199. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425–433. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  200. Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA. Identification of a tetrapeptide recognition sequence for the α2β1 integrin in collagen. J Biol Chem. 1991;266:7363–7367. [PubMed] [Google Scholar]
  201. Stallmach A, von Lampe B, Matthes H, Bornhoft G, Riecken EO. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malignant tumor transformation. Gut. 1992;33:342–346. doi: 10.1136/gut.33.3.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Ann Rev Biochem. 1988;57:593–625. doi: 10.1146/annurev.bi.57.070188.003113. [DOI] [PubMed] [Google Scholar]
  203. Steller H. Mechanisms and genes of cellular suicide. Science. 1995;267:145–1449. doi: 10.1126/science.7878463. [DOI] [PubMed] [Google Scholar]
  204. Streuli CH, Bailey N, Bissell MJ. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol. 1991;115(5):1383–1395. doi: 10.1083/jcb.115.5.1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Su L, Morgan PR, Lane EB. Protein and mRNA expression of simple epithelial keratins in normal, dysplastic, and malignant oral epithelia. Am J Pathol. 1994;145:1349–1357. [PMC free article] [PubMed] [Google Scholar]
  206. Symington BE. Fibronectin receptor modulates cyclin dependent kinase activity. J Biol Chem. 1993;268:21459–21462. [PubMed] [Google Scholar]
  207. Symington BE, Carter WG. Modulation of epidermal differentiation by epiligrin and integrin α3β1. J Cell Sci. 1995;108:831–838. doi: 10.1242/jcs.108.2.831. [DOI] [PubMed] [Google Scholar]
  208. Takada Y, Hemler ME. The primary substructure of the VLA-2/collagen receptor α2 subunit (platelet GPIa): Homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol. 1989;109:397–407. doi: 10.1083/jcb.109.1.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Takemoto Y, Fujimura Y, Matsumoto M, Tamai Y, Morita T, Matsushiro A, Nozaki M. The promoter of the endoA gene cytokeratin gene is activated by a 3′ downstream enhancer. Nuc Acids Res. 1991;19:2761–2765. doi: 10.1093/nar/19.10.2761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Tamai Y, Takemoto Y, Matsumoto M, Morita T, Matsushiro A, Nozaki M. Sequence of the EndoA gene encoding mouse cytokeratin and its methylation state in the CpG-rich region. Gene. 1991;104:169–176. doi: 10.1016/0378-1119(91)90247-9. [DOI] [PubMed] [Google Scholar]
  211. Tennenbaum PG, Weiner AK, Belanger AJ, Glick AB, Hennings H, Yuspa SH. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk of malignant progression in mouse skin carcinogenesis. Cancer Res. 1993;53:4803–4810. [PubMed] [Google Scholar]
  212. Thomas L, Chan PW, Chang S, Damsky C. 5-Bromo-2-deoxyuridine regulates invasiveness and expression of integrins and matrix-degrading proteinases in a differentiated hamster melanoma cell. J Cell Sci. 1993;105:191–201. doi: 10.1242/jcs.105.1.191. [DOI] [PubMed] [Google Scholar]
  213. Thorey IS, Cecena G, Reynolds, Oshima RG. Alu sequence involvement in transcriptional insulation of the keratin 18 gene in transgenic mice. Mol Cell Biol. 1993;13:6742–6751. doi: 10.1128/mcb.13.11.6742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Tyner AL, Fuchs E. Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis. J Cell Biol. 1986;103:1945–1955. doi: 10.1083/jcb.103.5.1945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Umezawa A, Yamamoto H, Rhodes K, Klemsz M, Maki RA, Oshima RG. Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression. Mol Cell Biol. 1997;17:4885–4894. doi: 10.1128/mcb.17.9.4885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC, Klein AJP. Expression of type IV collagenase and procollagen genes and its correlation with tumorigenic, invasive and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res. 1989;49:4615–4621. [PubMed] [Google Scholar]
  217. Uzan G, Prenant M, Prandini MH, Martin F, Marguerie G. Tissue-specific expression of the platelet GPIIb gene. J Biol Chem. 1991;266:8932–8939. [PubMed] [Google Scholar]
  218. Vansant G, Reynolds WF. The consensus sequence of a major Alu subfamily contains a functional retinoic acid response element. Proc Natl Acad Sci USA. 1995;92:8229–8233. doi: 10.1073/pnas.92.18.8229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. van Valen F, Hanenberg H, Jurgens H. Expression of functional very late antigen-alpha-1,-alpha-2,-alpha-3, and-alpha-6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumor cells and modulation by interferon-gamma and tumor necrosis factor-alpha. Eur J Can. 1994;30A:2119–2125. doi: 10.1016/0959-8049(94)00346-7. [DOI] [PubMed] [Google Scholar]
  220. Vasseur M, Duprey P, Brulet P, Jacob F. One gene and one pseudogene for cytokeratin endoA. Proc Natl Acad Sci USA. 1985;82:1155–1159. doi: 10.1073/pnas.82.4.1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Virtanen I, Laitinen A, Tani T, Pääkkö P, Laitinen LA, Burgeson RE, Lehto VP. Differential expression of laminins and their integrin receptors in developing and adult human lung. Am J Respir Cell Mol Biol. 1996;15:184–196. doi: 10.1165/ajrcmb.15.2.8703474. [DOI] [PubMed] [Google Scholar]
  222. Volpes R, van den Oord JJ, Desmet VJ. Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol. 1993;142:1483–1492. [PMC free article] [PubMed] [Google Scholar]
  223. Vuori K, Ruoslahti E. Activation of protein kinase C precedes α5β1 integrin-mediated cell spreading on fibronectin. J Cell Biol. 1993;268:21459–21462. [PubMed] [Google Scholar]
  224. Waseem A, Alexander CM, Steel JB, Lane EB. Embryonic simple epithelial keratins 8 and 18: chromosomal location emphasizes difference from other keratin pairs. New Biol. 1990;2:464–478. [PubMed] [Google Scholar]
  225. Weinel RJ, Rosendahl A, Pinschmidt E, Kisker O, Simon B, Santoso S. The alpha 6-integrin receptor in pancreatic carcinomas. Gastronerology. 1995;108:523–532. doi: 10.1016/0016-5085(95)90082-9. [DOI] [PubMed] [Google Scholar]
  226. Weitzman JB, Hemler ME, Brodt P. Reduction of tumorigenicity by α3 integrin in a rhabdomyosarcoma cell line. Cell Adhes Comm. 1996;4:41–52. doi: 10.3109/15419069609010762. [DOI] [PubMed] [Google Scholar]
  227. Wu JE, Santoro SA. Differential expression of integrin α subunits supports distinct roles during lung branching morphogenesis. Developmental Dynamics. 1996;206:169–181. doi: 10.1002/(SICI)1097-0177(199606)206:2<169::AID-AJA6>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  228. Xu J, Clark AF. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol. 1996;132:230–249. doi: 10.1083/jcb.132.1.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Yamamoto H, Irie A, Fukushima Y, Ohnishi T, Arita N, Hayakawa T, Sekiguchi K. Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin α6 subunit expression. Int J Cancer. 1996;65:519–524. doi: 10.1002/(SICI)1097-0215(19960208)65:4<519::AID-IJC21>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  230. Yao C-C, Breuss J, Pytela R, Kramer RH. Functional expression of the alpha 7 integrin receptor in differentiated smooth muscle cells. J Cell Sci. 1997;110:1477–1487. doi: 10.1242/jcs.110.13.1477. [DOI] [PubMed] [Google Scholar]
  231. Yebra M, Filardo E, Bayna E, Kawahara J, Cheresh D. Induction of carcinoma cell migration on vitronectin by NF-κB dependent gene expression. Mol Biol Cell. 1995;6:841–850. doi: 10.1091/mbc.6.7.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Yoshihara T, Hibi S, Tsunamoto K, Todo S, Imashuku S. Increased levels of αv-associated integrins associated with growth inhibition of cultured tumor cells by bromodeoxyuridine. Anticanc Res. 1997;17:833–838. [PubMed] [Google Scholar]
  233. Zhang Z, Tarone G, Turner DC. Expression of integrin α1β1 is regulated by nerve growth factor and dexamethasone in PC12 cells. J Biol Chem. 1993;268(8):5557–5565. [PubMed] [Google Scholar]
  234. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The α5β1integrin supports survival of cells on fibronectin and up-regulates bcl-2 expression. Proc Natl Acad Sci USA. 1995;92:6161–6165. doi: 10.1073/pnas.92.13.6161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Ziober BL, Lin CS, Kramer RH. Laminin-binding integrins in tumour progression and metastasis. Sem Can Biol. 1996;7:119–128. doi: 10.1006/scbi.1996.0017. [DOI] [PubMed] [Google Scholar]
  236. Zutter MM, Ryan EE, Painter AD. Binding of phosphorylated Sp1 protein to tandem Sp1 binding sites regulates alpha2 integrin gene core promoter activity. Blood. 1997;90(2):678–689. [PubMed] [Google Scholar]
  237. Zutter MM, Santoro SA, Painter AS, Tsung YL, Gafford A. The human α2 integrin gene promoter. J Biol Chem. 1994;269(1):463–469. [PubMed] [Google Scholar]
  238. Zutter MM, Santoro SA, Staatz WD, Tsung YL. Re-expression of the α2β1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA. 1995;92:7411–7415. doi: 10.1073/pnas.92.16.7411. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES